RenovoRx, Inc.

Initially reserved for only the most complex of tasks, robots have become the status quo in many surgical indications. Approximately 20% of surgeries performed in the US are done with robots and an ev

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. Astellas To Select Up To Five Targ

The IPO market slowed down in August but it looks like first-time offerings will regain their momentum in September, still on track for 2021 to be the most active year since the dot-com boom year of 2

The amount of venture capital raised during the second quarter of 2021 was almost double the total raised in the second quarter of 2020, but the biggest reason that biopharma financings jumped from $3